LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Replimune Group, Inc. ("Replimune" or ...
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL). Shareholders who purchased shares of REPL during the ...
TipRanks on MSN
Replimune’s Long-Term Safety Study: A Potential Game-Changer in Oncolytic Immunotherapy
Replimune Group (($REPL)) announced an update on their ongoing clinical study. Study Overview: Replimune Group is conducting a study titled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback